Navigation Links
Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
Date:4/18/2011

GAITHERSBURG, Md., April 18, 2011 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. is pleased to announce that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture L-asparaginase, the primary ingredient in the oncology medicine ONCASPAR® (pegaspargase).  ONCASPAR is the only FDA-approved PEGylated formulation of L-asparaginase which is a key component in the treatment of acute lymphoblastic leukemia (ALL). The attempt to secure approval to manufacture L-asparaginase came after the previous supplier decided to cease production, leading to a three-year development effort to create a comparable active ingredient.  The approval averts a potentially dangerous drug shortage situation in the U.S. which could have affected thousands of patients with ALL.

"To get a complex biologic medicine such as this exactly right takes a great deal of work for both the manufacturer and the FDA," said Gregg Lapointe, Chief Executive Officer, Sigma-Tau Pharmaceuticals, Inc.  "We are pleased to announce that with this approval, there will be no interruption in either the production of the medicine or in the treatment of patients with ALL."

L-asparaginase is an enzyme that depletes the amino acid asparagine, which certain leukemic cells are dependent upon for survival.  L-asparaginase was first approved in 1978 as a treatment for ALL. In 1994, the FDA approved the PEGylated formulation of the medicine (ONCASAPR) which has the unique therapeutic advantages of sustained duration and prolonged effect over the native L-asparaginase, resulting in enhanced convenience for patients and providers.  ONCASPAR is given to patients with ALL as part of a multi-agent chemotherapeutic treatment regimen.  Administering L-asparaginase results in the depletion of asparagine circulating in the blood, which starves the leukemic cells and results in their death.  ONCASPAR was updated to first-line indication in 2006.


'/>"/>
SOURCE Sigma-Tau Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... WASHINGTON , July 24, 2014  The ... Brightree is supporting its mission to help address ... new and exclusive agreement to be the information ... service. As the leading provider of billing and ... brings unmatched HME industry expertise to support this ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... 8, 2011 The U.S. Food and Drug Administration today launched ... the safe disposal of needles and other so-called "sharps" that ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The website will ... disposing of used sharps and how users should safely dispose ...
... Nov. 8, 2011 Dengue v2V, a group of international ... in Puerto Rico on 5–6 November 2011 to continue to ... licensed. Dengue is a threat to almost half of the ... and Asia where epidemics are common.(1) "Puerto ...
Cached Medicine Technology:FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 2FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 3FDA Launches Website on Safe Disposal of Used Needles and Other "Sharps" 4International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 2International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever 3
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
(Date:7/24/2014)... 24, 2014 This year the Walk ... Electric and Jackson National Life, will be held on Saturday, ... am, the Kids Fun Run at 7:50 am, the untimed ... 9 a.m. , “The Walk to End Alzheimer’s unites the ... in the fight against this devastating disease, “stated Linda Mitchell, ...
(Date:7/24/2014)... 24, 2014 (HealthDay News) -- Drinking caffeine may worsen ... two-thirds of women as they go through menopause, new ... our study suggests that limiting caffeine intake may be ... flashes and night sweats," said researcher Dr. Stephanie Faubion, ... Clinic in Rochester, Minn. But caffeine -- a ...
(Date:7/24/2014)... or more equally positive outcomes experience paradoxical feelings ... in different regions of the brain, according to ... scholar at the Princeton Neuroscience Institute at Princeton ... rated the desirability of more than 300 products ... images of paired products with different or similar ...
(Date:7/24/2014)... Le Bonheur Children,s Hospital and the University of Tennessee ... of a new drug shown to safely reduce the ... intranasally infected with respiratory syncytial virus (RSV). RSV is ... in young children in the United States and worldwide. ... Infectious Disease Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:RSV research breakthrough to help infected children 2
... with lung cancer remains to be established, a new ... Journal of Thoracic Oncology provides compelling evidence of ... Researchers at China Medical University and Hospital in Taiwan ... National Health Insurance (NHI) program. All patients aged 20 ...
... PROVIDENCE, R.I. [Brown University] A new study of ... seeking a hospice benefit and using it longer. The ... residents die with some degree of dementia. Researchers hope ... benefit even as they seek to control Medicare costs. ...
... By Dennis Thompson HealthDay Reporter , THURSDAY, ... played a big role in averting a major health crisis. ... pitch last winter, with public health officials fearing a widespread ... an epidemic was averted, and some health experts believe that,s ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- A treatment ... of patients suffering from multiple chronic illnesses such as ... in the Dec. 30 issue of the New ... four areas of blood sugar, blood pressure, cholesterol control ...
... Reporter , WEDNESDAY, Dec. 29 (HealthDay News) -- Consider this: ... cancer in the United States, killing about 157,300 people every ... according to the U.S. National Institutes of Health. , It ... only to heart disease. And yet lung cancer ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- People generally ... those of others, according to a new study. ... to 11 people. Each person talked with every other ... rated the other person,s physical attractiveness and five major ...
Cached Medicine News:Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Hospice care increasing for nursing home patients with dementia 2Health News:Hospice care increasing for nursing home patients with dementia 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 2Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 3Health News:Deadliest Cancer Getting Smaller Chunk of Research Dollars 4
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... More than a patch, Duragen is ... dura mater. Duragen handles and conforms ... an innovative collagen matrix for dural ... repair of dural defects. Fully resorbed ...
Elmed electrosurgical systems for major surgery....
Aaron 1250 is a multipurpose electrosurgical generator with monopolar and bi-polar functions....
Medicine Products: